Archer Daniels Midland Co.   Report issue

For profit Phase 2
Founded: Minneapolis MN United States (1902)
Status: No NME R&D (1902)

Organization Overview

First Clinical Trial
2007
NCT01314586
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

ADM Korea Inc | Probiotics International Ltd.